Trial Outcomes & Findings for Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT) (NCT NCT01004718)
NCT ID: NCT01004718
Last Updated: 2021-05-18
Results Overview
Lesional fluorodeoxyglucose (FDG) uptake is measured by standardized uptake value (SUV). The study compared the percentage of change in maximum SUV over 2 hours (first measure was 60 minutes post-administration and second timepoint was 180 minutes post-administration).
COMPLETED
NA
10 participants
2 hours (between 60 minutes post-administration and 180 minutes post-administration)
2021-05-18
Participant Flow
Participant milestones
| Measure |
Fludeoxyglucose F18 (FDG) PET/CT Scans
Patients undergo fludeoxyglucose F18 (FDG) positron emission tomography/computed tomography scans and 180 minutes after FDG administration.
Fludeoxyglucose F18: Undergo FDG PET/CT scans
Computed Tomography: Undergo FDG PET/CT scans
Positron emission tomography: Undergo FDG PET/CT scans
|
|---|---|
|
Overall Study
STARTED
|
10
|
|
Overall Study
COMPLETED
|
10
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)
Baseline characteristics by cohort
| Measure |
Fludeoxyglucose F18 (FDG) PET/CT Scans
n=10 Participants
Patients undergo fludeoxyglucose F18 (FDG) positron emission tomography/computed tomography scans and 180 minutes after FDG administration.
Fludeoxyglucose F18: Undergo FDG PET/CT scans
Computed Tomography: Undergo FDG PET/CT scans
Positron emission tomography: Undergo FDG PET/CT scans
|
|---|---|
|
Age, Continuous
|
47 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
4 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
10 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 2 hours (between 60 minutes post-administration and 180 minutes post-administration)Lesional fluorodeoxyglucose (FDG) uptake is measured by standardized uptake value (SUV). The study compared the percentage of change in maximum SUV over 2 hours (first measure was 60 minutes post-administration and second timepoint was 180 minutes post-administration).
Outcome measures
| Measure |
Diffuse Large B-cell Lymphoma
n=5 Participants
Patients undergo fludeoxyglucose F18 (FDG) positron emission tomography/computed tomography scans and 180 minutes after FDG administration.
|
Hodgkin's Lymphoma
n=5 Participants
Patients undergo fludeoxyglucose F18 (FDG) positron emission tomography/computed tomography scans and 180 minutes after FDG administration.
|
|---|---|---|
|
Percentage Change in Maximum Lesional FDG Uptake From 60 to 180 Minutes After FDG Administration
|
36.2 percentage of change in maximum SUV
Standard Deviation 12.4
|
32 percentage of change in maximum SUV
Standard Deviation 11.6
|
Adverse Events
Fludeoxyglucose F18 (FDG) PET/CT Scans
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place